Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Much Will The Nanomedicine Market Be Worth By 2029?

The scale of the nanomedicine market has experienced a swift expansion over the last few years. The market is predicted to enlarge from $331.61 billion in 2024 to $375.87 billion in 2025, achieving a Compound Annual Growth Rate (CAGR) of 13.3%. Factors underlying this growth during the historic period include the improved knowledge of molecular biology, the escalating occurrence of long-term illnesses, rising demand for specific drug delivery systems, growth of nanoparticle imaging technologies, and an ever-increasing elderly populace.

The market size of nanomedicine is projected to experience a significant increase in the upcoming years, reaching “$676.38 billion in 2029 with a compound annual growth rate (CAGR) of 15.8%. Factors contributing to this surge during the forecast period include sustained growth in nanotechnology studies, heightened investment in nanomedicine research and development, a greater emphasis on personalized medicine, broader use of nanomedicine in cancer care, and the inclusion of nanomedicine in the treatment of infectious diseases. Predicted trends for the period include the creation of multi-functional nanoparticles for therapeutics and imaging, a focus on nanoparticle-based diagnostics and imaging agents, the application of nanomedicine within regenerative medicine, increased employment of nanomedicine for targeted therapy in neurological ailments, and partnerships and collaborations in nanomedicine research and market introduction.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5344&type=smp

What External And Internal Drivers Are Influencing The Nanomedicine Market?

The escalating incidence of intricate and enduring illnesses worldwide is anticipated to spur the expansion of the nanomedicine market during the prognostication span. The utility of nanomedicine is progressively amplifying in the therapy of chronic ailments such as heart complications, metabolic diseases, cancer, cognitive disorders, and more, where it promotes quick drug metabolism in the body. To illustrate, Alzheimer’s Disease International, the global federation of Alzheimer’s Associations, reveals that over 50 million people worldwide are currently afflicted with cognitive disorders, with predictions for these figures to double every 2 decades ultimately reaching 80 million by 2030 and 152 million by 2050. Moreover, worldwide cancer cases are anticipated to surge to 28.4 million fresh cases by 2040. This mounting prevalence of chronic diseases is projected to heighten the requirement for potent therapeutic treatments employing nanomedicine, thereby fuelling the growth of the nanomedicine market.

What Segmentation Insights Are Provided In The Nanomedicine Market Research?

The nanomedicine market covered in this report is segmented –

1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types

2) By Modality: Diagnostics, Treatments

3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications

Subsegments:

1) By Nanoparticles: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Ceramic Nanoparticles

2) By Nanoshells: Gold Nanoshells, Silver Nanoshells, Silica Nanoshells

3) By Nanotubes: Carbon Nanotubes (CNTs), Polymer Nanotubes

4) By Nanodevices: Nanosensors, Nanorobots, Nanoscale Imaging Devices

5) By Other Types: Dendrimers, Quantum Dots, Nanocarriers

Which Notable Trends Are Transforming The Nanomedicine Market Outlook?

Key players in the nanomedicine market are pushing their revenues by introducing innovative products like dynapro zetastar. This unique tool allows for concurrent dynamic and static light scattering measurements, as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). In 2023, Waters Corporation, a US-based firm renowned for their analytical laboratory gear and instruments, introduced dynapro zetastar designed for nanoparticle analysis. The application of zetastar provides accurate development of multifaceted biologics, combining multiple light scattering methods, undertaking adaptive data capture, automatically assessing the quality of data, and boosting sensitivity and speed of measurements with incredibly small sample sizes. With its singular flow cell design, the zetastar instrument can be seamlessly connected to an autosampler, improving lab productivity and efficiency by facilitating numerous unattended measurements over several hours, or even over an entire night.

Who Are The Leading Companies Driving The Nanomedicine Market?

Major companies operating in the nanomedicine market include Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Nanomedicine Market?

North America was the largest region in the nanomedicine market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=5344&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model